BYAH

Park Ha Biological Technology Co., Ltd. Ordinary SharesNASDAQConsumer Cyclical

$1.05+0.96%ClosedMarket Cap: $711,332

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

0.15

P/S

0.28

EV/EBITDA

0.12

DCF Value

$-9.66

FCF Yield

-0.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

90.6%

Operating Margin

-956.5%

Net Margin

-965.0%

ROE

-591.0%

ROA

-409.3%

ROIC

-578.4%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$1.3M	86.2%	$-4.4M	$-4.5M	$-7.61	—
FY 2025	$2.5M	94.4%	$-24.1M	$-24.4M	$-41.38	—
Q2 2025	$1.2M	95.3%	$-19.7M	$-19.8M	$-33.76	—
Q1 2025	$1.2M	95.3%	$-19.7M	$-19.8M	$-34.00	—
FY 2024	$2.4M	91.8%	$793.7K	$478.6K	$0.92	—
FY 2023	$2.5M	87.4%	$1.2M	$852.0K	$1.63	—
FY 2022	$1.9M	73.5%	$197.0K	$191.3K	$0.37	—
FY 2021	$931.0K	66.6%	$-501.0K	$-485.0K	$-0.93	—